Projeto
Ocean bioprospecting: targeting marine actinomycetes as a source for lead-like drug discovery
| Referência: | IF/00700/2014/CP1224/CT0007 |
|---|---|
| Programa de financiamento: | Investigador FCT |
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade Nova de Lisboa |
Registos relacionados
Novel antivirals against Influenza: NS1 target validation and lead discovery
DRUG DISCOVERY FOR p53 PPI-TARGETS
DRUG DISCOVERY FOR p53 PPI-TARGETS
Aquaporins in metabolic syndrome:new targets for drug discovery
Development of new drug leads for tuberculosis
Targeting the proteasome in anticancer therapy by a computational based drug discovery approach
Center for Drug Discovery and Innovative Medicines
Center for Drug Discovery and Innovative Medicines
Exploitation of a scorpion-derived alkaloid for drug discovery
Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease
Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease
Combinatorial Antibody Synthesis for the discovery of Targeted Immunomodulators
Novel chembiochemical properties of marine actinomycetes Streptomyces aculeolatus spp. unveleid by a combined proteomic and metabolomic approach
Developing spirolactone as a new antifungal drug lead to treat aspergillosis [NNF23OC0082881]
Novel therapeutic approach to ALS: targeting aberrant-like astrocytes before transplantation
Amaryllidaceae-type alkaloids as anticancer hit/leads, targeting multidrug resistant cancer cells
Amaryllidaceae-type alkaloids as anticancer hit/leads, targeting multidrug resistant cancer cells
Deep Drug Discovery and Deployment [PTDC/CCI-BIO/29266/2017]
Induction of juvenile-like plasticity in the adult brain
Hepatocytes-Like Microreactors for Liver Tissue Engineering
A Systems Biology approach to model COVID19 phenotypes and drive drug discovery [2020.10205.BD]
Ocean Treasures - Ocean sediments from Madeira Archipelago: a new source of innovative and bioactive compounds.
HIGH-THROUGHPUT CLONING OF VENOM PEPTIDES FOR DISCOVERY OF NOVEL THERAPEUTIC PEPTIDES AND INNOVATIVE DRUG DEVELOPMENT
BIOMYSKIN – Biomimicry profiling supporting drug discovery for topical applications [SFRH/BD/147938/2019]
A nanotechnology approach to Flavivirus-targeted drug development strategies
A nanotechnology approach to Flavivirus-targeted drug development strategies
WELCOME II - MARINE BACTERIA AS A NOVEL RESOURCE FOR BRUG DISCOVERY
Selecting anti-Zika virus drug leads able to translocate the blood-placental and blood-brain barriers. Combining innovative and effective translocating peptides with new antivirals to target Zika across barriers.
Bioprospection, study and application of bioactive compounds from microalgae and seaweeds
Grapevine immunity: the innovative role of subtilisin-like proteases
Screening and pharmacological characterization of flavonoids as lead compounds for obesity treatment
A computer-aided platform to design and exploit non-ribosomal peptide synthetases for drug discovery [VI.Veni.202.130]
FROM A MULTITARGET ANTIDIABETIC GLYCOSYL ISOFLAVONE TOWARDS NEW MOLECULAR ENTITIES AGAINST DIABETES AND ALZHEIMERS DISEASE: GENERATION OF LEAD DERIES AND TARGET ASSESSMENT
THERAPEUTIC ACTIVITY OF A TARGETED DRUG DELIVERY APPROACH ON TUMOR METASTASIZATION
Discovery of new antimicrobial drugs active against resistant pathogen agents: The case study of Portuguese Asphodelus species
Development of a Text Mining Approach to Disease Network Discovery
New drugs to target Neurodegenerattion and Neuroinflammation in Parkinson ´s Disease
Biodiversity and Bioprospection of Biosurfactants In Saline environments [PTDC/BII-BIO/5554/2020]
In the limelight of newly synthesized fluorescent nucleoside derivatives for bioimaging and drug discovery: high-throughput computational drug design and live-cell pharmacological assessments [2023.01949.BD]
Grapevine resistance to downy mildew: the innovative role of subtilisin-like proteases
Publicações relacionadas
Carregando publicações...